Evidence map›Paper›PMID 22674256›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

GSK3 temporally regulates neurogenin 2 proneural activity in the neocortex.

Saiqun Li, Pierre Mattar, Dawn Zinyk, Kulwant Singh, Chandra-Prakash Chaturvedi, Christopher Kovach, Rajiv Dixit, Deborah M Kurrasch, Yong-Chao Ma, Jennifer A Chan and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Saiqun LiHotchkiss Brain Institute and Alberta Children's Hospital Research Institute, Department of Biochemistry, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Pierre Mattar
Dawn Zinyk
Kulwant Singh
Chandra-Prakash Chaturvedi
Christopher Kovach
Rajiv Dixit
Deborah M Kurrasch
Yong-Chao Ma
Jennifer A Chan
Valerie Wallace
F Jeffrey Dilworth
Marjorie Brand
Carol Schuurmans
University of Calgary · CAUniversity of Ottawa · CAAlberta Children's Hospital · CANorthwestern University · US

Funding

Canadian Institutes of Health Research MOP-44094
6 · The paper itself

Abstract

The neocortex is comprised of six neuronal layers that are generated in a defined temporal sequence. While extrinsic and intrinsic cues are known to regulate the sequential production of neocortical neurons, how these factors interact and function in a coordinated manner is poorly understood. The proneural gene Neurog2 is expressed in progenitors throughout corticogenesis, but is only required to specify early-born, deep-layer neuronal identities. Here, we examined how neuronal differentiation in general and Neurog2 function in particular are temporally controlled during murine neocortical development. We found that Neurog2 proneural activity declines in late corticogenesis, correlating with its phosphorylation by GSK3 kinase. Accordingly, GSK3 activity, which is negatively regulated by canonical Wnt signaling, increases over developmental time, while Wnt signaling correspondingly decreases. When ectopically activated, GSK3 inhibits Neurog2-mediated transcription in cultured cells and Neurog2 proneural activities in vivo. Conversely, a reduction in GSK3 activity promotes the precocious differentiation of later stage cortical progenitors without influencing laminar fate specification. Mechanistically, we show that GSK3 suppresses Neurog2 activity by influencing its choice of dimerization partner, promoting heterodimeric interactions with E47 (Tcfe2a), as opposed to Neurog2-Neurog2 homodimer formation, which occurs when GSK3 activity levels are low. At the functional level, Neurog2-E47 heterodimers have a reduced ability to transactivate neuronal differentiation genes compared with Neurog2-Neurog2 homodimers, both in vitro and in vivo. We thus conclude that the temporal regulation of Neurog2-E47 heterodimerization by GSK3 is a central component of the neuronal differentiation "clock" that coordinates the timing and tempo of neocortical neurogenesis in mouse.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCells, CulturedChromatin ImmunoprecipitationChromatography, GelCloning, MolecularDimerizationElectroporationFemaleGenes, ReporterGlycogen Synthase Kinase 3Half-LifeHelix-Loop-Helix MotifsImmunohistochemistryIn Situ HybridizationMiceBasic Helix-Loop-Helix ProteinsGlycogen Synthase Kinase 3Nerve Tissue ProteinsNeurog2 protein, mouse

Identifiers

PMID22674256
PMCPMC6620952
OpenAlexW2125715661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.